Haemonetics announced today that it entered into an agreement to acquire Attune Medical. Boston-based Haemonetics agreed to buy Attune for an upfront cash payment of $160 million. The deal also includes additional contingent consideration based on sales growth in the three years following the consummation of the acquisition. These additional payments also hinge on other […]
Mergers & Acquisitions
Baxter in talks over Kidney Care sale, expects separation later this year
Baxter today shared an update on the planned separation of its Kidney Care business as it looks at a potential sale instead of a spinoff. In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the […]
Boston Scientific prices €2B offering to finance Axonics buy
Boston Scientific announced that it priced an offering worth nearly $2.2 billion (€2 billion) in senior notes. American Medical Systems Europe B.V., Boston Scientific’s wholly-owned finance subsidiary, priced the public offering. It includes €750,000,000 aggregate principal amount of 3.375% notes due in 2029 and €1,250,000,000 aggregate principal amount of 3.500% notes due in 2032. Notes […]
DarioHealth acquires digital health company Twill, prices $22.4M offering
DarioHealth (Nasdaq:DRIO) announced today that it acquired digital-led care leader Twill and priced a $22.4 million private placement. New York-based DarioHealth says the acquisition enables it to create a comprehensive digital platform for chronic conditions. This offering would span a wide spectrum of health and wellbeing needs, from emotional health to chronic conditions. The company […]
AngioDynamics sells PICC and Midline portfolios for $45M, discontinues sales of radiofrequency ablation devices
AngioDynamics recently announced the sale of its PICC and Midline product portfolios to Spectrum Vascular for up to $45 million in cash. The company PICC, Midline and tip location products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023. The transaction consists of $34.5 million paid at closing, an earnout related to […]
Ablation tech developer Adagio Medical to go public in SPAC deal
Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name “Adagio Medical.” Arya expects to list the combined company’s […]
Zeda acquires The Orthopedic Implant Company
Zeda announced today that it agreed to acquire The Orthopaedic Implant Company (OIC) for an undisclosed amount. San Francisco-based Zeda says the acquisition marks a “significant leap forward” in strengthening its commitment to “revolutionizing manufacturing and distribution of medical devices globally.” OIC delivers high-quality, cost-effective orthopedic devices, Zeda said in a news release. The company […]
ReWalk Robotics looks to the future following Lifeward rebrand
On Jan. 29, ReWalk Robotics announced a rebrand to “Lifeward.” The rebrand had, in many ways, been in the works for about six months. Really, though, Lifeward CEO Larry Jasinski started formulating this plan a few years ago. All it needed was a few key ingredients to propel the physical rehabilitation and recovery company forward. […]
BCI developer Synchron buys stake in thin film maker Acquandas
Synchron, a developer of brain-computer interface (BCI) technology, today announced the acquisition of an equity stake in Acquandas. Acquandas, a German-based company, specializes in high-precision components for healthcare and other industries. The company bases its metallic components on state-of-the-art microsystem technology processes. It fabricates thin film components for applications in medical devices, including micro-patterned nitinol […]
ReWalk Robotics rebrands to ‘Lifeward’ as portfolio expands
ReWalk Robotics (Nasdaq:RWLK) today unveiled new corporate branding to officially begin operating as “Lifeward.” Beginning today, the company operates as Lifeward. Starting tomorrow, Jan. 30, 2024, its shares begin trading under the “LFWD” ticker on the Nasdaq market. Lifeward aims to deliver solutions for rehabilitation, recovery and more in the face of physical limitation or […]
Olympus completes acquisition of GI stent maker Taewoong Medical
Olympus announced today that it closed its acquisition of Taewoong Medical, a Korea-based medical device manufacturer. Taewoong Medical develops gastrointestinal (GI) metallic stents, among other offerings. Olympus announced its intent to acquire the company for $370 million in February 2023. The deal includes $255.5 million upfront, with up to $114.5 million in potential milestone payments […]